(Q74315744)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11487459%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Antithrombotic Secondary Prevention After Stroke (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11487459%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11487459%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Hans-Christoph Diener

series ordinal

1

object named as

Hans-Christoph Diener

1 reference

10 November 2019

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11487459%20AND%20SRC:MED&resulttype=core&format=json

Current treatment options in neurology

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11487459%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11487459%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11487459%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

451-462

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11487459%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11940-001-0033-6

10 November 2019

exact match

0 references

cites work

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

12 December 2020

Second European Stroke Prevention Study. ESPS-2 Working Group

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura related to ticlopidine

1 reference

12 December 2020

Platelet GPIIb-IIIa blockers

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura associated with clopidogrel

1 reference

12 December 2020

A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group

1 reference

12 December 2020

Platelet-active drugs: the relationships among dose, effectiveness, and side effects.

1 reference

12 December 2020

Statins for prevention of stroke

1 reference

12 December 2020

A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke

1 reference

12 December 2020

Low-dose aspirin and stroke. "It ain't necessarily so"

1 reference

12 December 2020

The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group

1 reference

12 December 2020

Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST)

1 reference

12 December 2020

Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo

1 reference

12 December 2020

Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis

1 reference

12 December 2020

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

The Warfarin-Aspirin Symptomatic Intracranial Disease Study.

1 reference

12 December 2020

Controversies in stroke: past and present. The Willis Lecture

1 reference

12 December 2020

Pravastatin Therapy and the Risk of Stroke

1 reference

12 December 2020

Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia

1 reference

12 December 2020

Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

12 December 2020

Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group

1 reference

12 December 2020

Vascular event rates in patients with atherosclerotic cerebrovascular disease

1 reference

12 December 2020

"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia

1 reference

12 December 2020

Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project

1 reference

12 December 2020

European Stroke Prevention Study 2. Efficacy and safety data

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

1 reference

12 December 2020

Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group

1 reference

12 December 2020

Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Current management of amaurosis fugax. The Amaurosis Fugax Study Group

1 reference

12 December 2020

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura after stenting and ticlopidine

1 reference

12 December 2020

[Prevention of recurrences of cerebral ischemic vascular accidents by platelet antiaggregants. Results of a 3-year controlled therapeutic trial]

1 reference

12 December 2020

Aspirin in ischemic cerebrovascular disease. How strong is the case for a different dosing regimen?

1 reference

12 December 2020

Design of the Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion (BRAVO) trial

1 reference

12 December 2020

Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke : Gathering the Evidence

1 reference

12 December 2020

Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors

1 reference

12 December 2020

Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final rule for professional labeling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products; technical amendments. Departm

1 reference

12 December 2020

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

1 reference

12 December 2020

CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group

1 reference

12 December 2020

Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.

1 reference

12 December 2020

Atrial fibrillation and stroke. Revisiting the dilemmas

1 reference

12 December 2020

10.1007/S11940-001-0033-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11487459%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference